WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FOLD

Based on 6 analysts offering 12 month price targets for Amicus Therapeutics Inc

Min Forecast
$11.00-23.66%
Avg Forecast
$14.67+1.78%
Max Forecast
$19.00+31.85%

Should I buy or sell FOLD stock?

Based on 6 analysts offering ratings for Amicus Therapeutics Inc.

Hold
Strong Buy
1 analysts 16.67%
Buy
0 analysts 0%
Hold
5 analysts 83.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FOLD stock forecasts and price targets.

FOLD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-22
lockedlocked$00.00+00.00%2025-12-29
lockedlocked$00.00+00.00%2025-12-22
lockedlocked$00.00+00.00%2025-12-19
lockedlocked$00.00+00.00%2025-11-06Find Out Why
Goldman Sachs
Top 19%
82
HoldMaintains$11.00-23.66%2025-11-05

1 of 1

Forecast return on equity

Is FOLD forecast to generate an efficient return?

Company
242.92%
Industry
68.5%
Market
178.91%
FOLD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FOLD forecast to generate an efficient return on assets?

Company
70.13%
Industry
31.48%
FOLD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FOLD earnings per share forecast

What is FOLD's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$0.34
Avg 2 year Forecast
$0.68
Avg 3 year Forecast
$0.89

FOLD revenue forecast

What is FOLD's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$764.2M+20.5%
Avg 2 year Forecast
$906.3M+42.91%
Avg 3 year Forecast
$1.1B+71.87%
FOLD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FOLD revenue growth forecast

How is FOLD forecast to perform vs Biotechnology companies and vs the US market?

Company
19.4%
Industry
35.26%
Market
13.29%
FOLD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FOLD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FOLD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FOLD$14.41$14.67+1.78%Hold
TERN$50.00$53.75+7.50%Strong Buy
ERAS$14.67$15.11+3.01%Strong Buy
CRSP$46.43$74.27+59.97%Buy
XENE$53.38$72.44+35.71%Strong Buy
View Top Biotech Stocks

Amicus Therapeutics Stock Forecast FAQ

Is Amicus Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: FOLD) stock is to Hold FOLD stock.

Out of 6 analysts, 1 (16.67%) are recommending FOLD as a Strong Buy, 0 (0%) are recommending FOLD as a Buy, 5 (83.33%) are recommending FOLD as a Hold, 0 (0%) are recommending FOLD as a Sell, and 0 (0%) are recommending FOLD as a Strong Sell.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.

What is FOLD's earnings growth forecast for 2026-2028?

(NASDAQ: FOLD) Amicus Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.77%.

Amicus Therapeutics's earnings in 2026 is -$27,110,000.On average, 11 Wall Street analysts forecast FOLD's earnings for 2026 to be $107,168,443, with the lowest FOLD earnings forecast at $73,852,967, and the highest FOLD earnings forecast at $183,659,016. On average, 10 Wall Street analysts forecast FOLD's earnings for 2027 to be $211,981,881, with the lowest FOLD earnings forecast at $95,393,416, and the highest FOLD earnings forecast at $290,136,658.

In 2028, FOLD is forecast to generate $279,711,834 in earnings, with the lowest earnings forecast at $233,867,730 and the highest earnings forecast at $309,918,703.

What is FOLD's revenue growth forecast for 2026-2028?

(NASDAQ: FOLD) Amicus Therapeutics's forecast annual revenue growth rate of 19.4% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.26%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.29%.

Amicus Therapeutics's revenue in 2026 is $634,210,000.On average, 11 Wall Street analysts forecast FOLD's revenue for 2026 to be $239,965,624,125, with the lowest FOLD revenue forecast at $226,444,753,466, and the highest FOLD revenue forecast at $258,155,685,371. On average, 10 Wall Street analysts forecast FOLD's revenue for 2027 to be $284,585,125,300, with the lowest FOLD revenue forecast at $260,331,710,305, and the highest FOLD revenue forecast at $310,612,644,318.

In 2028, FOLD is forecast to generate $342,260,776,080 in revenue, with the lowest revenue forecast at $311,476,146,276 and the highest revenue forecast at $368,322,835,176.

What is FOLD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: FOLD) forecast ROA is 70.13%, which is higher than the forecast US Biotechnology industry average of 31.48%.

What is FOLD's Price Target?

According to 6 Wall Street analysts that have issued a 1 year FOLD price target, the average FOLD price target is $14.67, with the highest FOLD stock price forecast at $19.00 and the lowest FOLD stock price forecast at $11.00.

On average, Wall Street analysts predict that Amicus Therapeutics's share price could reach $14.67 by Jan 22, 2027. The average Amicus Therapeutics stock price prediction forecasts a potential upside of 1.78% from the current FOLD share price of $14.41.

What is FOLD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: FOLD) Amicus Therapeutics's current Earnings Per Share (EPS) is -$0.09. On average, analysts forecast that FOLD's EPS will be $0.34 for 2026, with the lowest EPS forecast at $0.24, and the highest EPS forecast at $0.58. On average, analysts forecast that FOLD's EPS will be $0.68 for 2027, with the lowest EPS forecast at $0.30, and the highest EPS forecast at $0.92. In 2028, FOLD's EPS is forecast to hit $0.89 (min: $0.74, max: $0.99).

What is FOLD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: FOLD) forecast ROE is 242.92%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.